Does TICAGRELOR Cause Basal cell carcinoma? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Basal cell carcinoma have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.1% of all adverse event reports for TICAGRELOR.
22
Reports of Basal cell carcinoma with TICAGRELOR
0.1%
of all TICAGRELOR reports
0
Deaths
14
Hospitalizations
How Dangerous Is Basal cell carcinoma From TICAGRELOR?
Of the 22 reports, 14 (63.6%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which TICAGRELOR Alternatives Have Lower Basal cell carcinoma Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN